Big Pharma Bets on Toad Venom and Magic Mushrooms as New Drugs

Major pharmaceutical companies are pouring money into drugs based on psychedelic substances, including bufotenin from toad venom and psilocybin from magic mushrooms. The push is encouraged by the Trump administration's openness to approving such therapies. According to CNBC, companies are hoping for regulatory green lights for these new compounds.